Eric Ciamporcero Selected Research

Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)

2/2015

Tasquinimod modulates suppressive myeloid cells and enhances cancer immunotherapies in murine models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric Ciamporcero Research Topics

Disease

15	Neoplasms (Cancer) 05/2022 - 01/2011
6	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 01/2014
5	Prostatic Neoplasms (Prostate Cancer) 02/2015 - 01/2011
3	Melanoma (Melanoma, Malignant) 12/2015 - 12/2013
2	Neoplasm Metastasis (Metastasis) 01/2020 - 02/2015
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2018 - 11/2016
2	Colonic Neoplasms (Colon Cancer) 01/2012 - 01/2012
1	Triple Negative Breast Neoplasms 03/2021
1	Hypoxia (Hypoxemia) 01/2016
1	Disease Progression 02/2015
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2014
1	Breast Neoplasms (Breast Cancer) 12/2013
1	Hyperlipidemias (Hyperlipidemia) 01/2012
1	Cardiomyopathies (Cardiomyopathy) 10/2011
1	Atherosclerotic Plaque (Atheroma) 10/2011
1	Neointima 10/2011
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2011
1	Inflammation (Inflammations) 10/2011
1	Atherosclerosis 10/2011
1	Hemorrhage 10/2011

Drug/Important Bio-Agent (IBA)

4	Sunitinib (Sutent)FDA Link 12/2017 - 01/2014
4	4-hydroxy-2-nonenal (4-hydroxynonenal)IBA 12/2015 - 01/2011
3	Pharmaceutical PreparationsIBA 01/2018 - 02/2015
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2013
2	Cisplatin (Platino)FDA LinkGeneric 03/2021 - 11/2016
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020 - 12/2017
2	Antineoplastic Agents (Antineoplastics)IBA 02/2015 - 01/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015 - 01/2014
2	Tyrosine Kinase InhibitorsIBA 01/2015 - 01/2014
2	LigandsIBA 01/2014 - 01/2012
2	CyclodextrinsIBA 12/2013 - 11/2012
2	1,3- benzothiazol- 2- yl(2- ((2- (3- pyridinyl)ethyl)amino)- 4- pyrimidinyl)acetonitrileIBA 01/2012 - 01/2012
1	olaparibIBA 05/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2022
1	cisplatin-DNA adductIBA 03/2021
1	AngiopoietinsIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	trebananibIBA 01/2020
1	AntioxidantsIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Cytotoxins (Cytolysins)IBA 01/2018
1	Histones (Histone)IBA 12/2017
1	TransferasesIBA 12/2017
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2016
1	ChromatinIBA 01/2016
1	Protein Isoforms (Isoforms)IBA 01/2016
1	cobaltous chloride (cobalt(II)chloride)IBA 01/2016
1	NanocapsulesIBA 12/2015
1	SuperantigensIBA 02/2015
1	Cancer VaccinesIBA 02/2015
1	tasquinimodIBA 02/2015
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2015
1	CrizotinibIBA 01/2015
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2015
1	Axitinib (AG 013736)IBA 01/2015
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2015
1	afliberceptIBA 01/2014
1	AldehydesIBA 12/2013
1	Dietary ProteinsIBA 12/2013
1	Plant ProteinsIBA 12/2013
1	Histone MethyltransferasesIBA 12/2013
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2013
1	A 7 (A-7)IBA 12/2013
1	Insulin-Like Growth Factor I (IGF-1)IBA 12/2013
1	AndrogensIBA 11/2012
1	CamptothecinIBA 11/2012
1	Topoisomerase I InhibitorsIBA 11/2012
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2012
1	Clofibrate FDA Link 01/2012
1	Rosiglitazone (Avandia)FDA Link 01/2012
1	ciprofibrateIBA 01/2012
1	Fibric Acids (Fibrates)IBA 01/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2011
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2011
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2011
1	Thromboplastin (Tissue Factor)IBA 10/2011
1	Histone Deacetylase InhibitorsIBA 01/2011
1	PanobinostatIBA 01/2011

Therapy/Procedure

5	Therapeutics 01/2020 - 10/2011
1	Nephrectomy 01/2016
1	Topical Administration 12/2015
1	Castration 02/2015
1	Immunotherapy 02/2015
1	Heart Transplantation (Grafting, Heart) 10/2011